Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -0.92% is 95% above its 5-year average of -16.86%, around the middle of its 5-year range (-187.03%–86.27%).
72.16% above its 12-month average of -3.30%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.19%.
OPERATING MARGIN
-0.92%
OPERATING MARGIN AVG TTM
-3.30%
OPERATING MARGIN AVG 3Y
-14.14%
OPERATING MARGIN AVG 5Y
-16.86%
OPERATING MARGIN AVG 10Y
-20.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+72.16%
CURRENT VS 3Y AVG
+93.49%
CURRENT VS 5Y AVG
+94.54%
CURRENT VS 10Y AVG
+95.40%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$3.62B
Operating Margin
-72.84%
TTM Avg
-2371.95%
3Y Avg
-1360.37%
5Y Avg
-967.05%
Market Cap
$3.58B
Operating Margin
-1.17%
TTM Avg
-12.22%
3Y Avg
-19.38%
5Y Avg
-20.83%
Market Cap
$3.44B
Operating Margin
7.59%
TTM Avg
16.94%
3Y Avg
-4.86%
5Y Avg
-19.92%
Market Cap
$3.25B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.16B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-93.42%
5Y Avg
-160.46%
Market Cap
$3.15B
Operating Margin
-3.25%
TTM Avg
-34.29%
3Y Avg
-2164.03%
5Y Avg
-1442.69%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CareDx, Inc (CDNA) | $3.61B | -0.92% | -3.30% | -14.14% | -16.86% |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.62B | -72.84% | -2371.95% | -1360.37% | -967.05% |
| Celcuity Inc. (CELC)vs › | $3.59B | 0.00% | 0.00% | 0.00% | 0.00% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.58B | -1.17% | -12.22% | -19.38% | -20.83% |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 7.59% | 16.94% | -4.86% | -19.92% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | 0.00% | 0.00% | 0.00% | 0.00% |
| ICU Medical, Inc. (ICUI)vs › | $4.03B | 5.04% | 3.30% | 1.43% | 3.80% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | 0.00% | 0.00% | -93.42% | -160.46% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | -3.25% | -34.29% | -2164.03% | -1442.69% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | 0.00% | -180.11% | -313.94% | -1209.42% |
Gross Margin
70.6%
Operating Margin
-0.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.19% |
| 2026-03-31 | 1.53% |
| 2025-12-31 | -5.57% |
| 2025-09-30 | -0.25% |
| 2025-06-30 | -12.43% |
| 2025-03-31 | -9.46% |
| 2024-12-31 | 86.27% |
| 2024-09-30 | -12.66% |
| 2024-06-30 | -7.94% |
| 2024-03-31 | -26.84% |
| 2023-12-31 | -187.03% |
| 2023-09-30 | -42.84% |
| 2023-06-30 | -39.29% |
| 2023-03-31 | -31.48% |
| 2022-12-31 | -23.21% |
| 2022-09-30 | -21.85% |
| 2022-06-30 | -26.94% |
| 2022-03-31 | -23.99% |
| 2021-12-31 | -19.44% |
| 2021-09-30 | -11.55% |
| 2021-06-30 | -6.39% |
| 2021-03-31 | -1.27% |
| 2020-12-31 | -5.23% |
| 2020-09-30 | -5.45% |
| 2020-06-30 | -25.84% |
| 2020-03-31 | -14.98% |
| 2019-12-31 | -15.48% |
| 2019-09-30 | -19.96% |
| 2019-06-30 | -21.76% |
| 2019-03-31 | -20.77% |
| 2018-12-31 | -10.27% |
| 2018-09-30 | -12.84% |
| 2018-06-30 | -29.23% |
| 2018-03-31 | -37.25% |
| 2017-12-31 | -34.29% |
| 2017-09-30 | -31.70% |
| 2017-06-30 | -29.88% |
| 2017-03-31 | -73.76% |
| 2016-12-31 | -173.67% |
| 2016-09-30 | -39.54% |
| 2016-06-30 | -63.96% |
| 2016-03-31 | -100.11% |
| 2015-12-31 | -67.12% |
| 2015-09-30 | -44.65% |
| 2015-06-30 | -40.48% |
| 2015-03-31 | -19.28% |
| 2014-12-31 | 5.39% |
| 2014-09-30 | 20.93% |
| 2014-06-30 | -5.09% |
| 2014-03-31 | -3.83% |
| 2013-12-31 | 8.69% |
| 2013-09-30 | -5.72% |
| 2013-06-30 | -4.69% |
| 2013-03-31 | -15.62% |
